Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease.

Ye Z, Wang S, Yang Z, He M, Zhang S, Zhang W, Wen J, Li Q, Huang Y, Wang X, Lu B, Zhang Z, Su Q, Hu R.

Mol Biol Rep. 2014 Mar;41(3):1317-23. doi: 10.1007/s11033-013-2977-5. Epub 2014 Jan 4.

PMID:
24390241
2.

Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.

Milner KL, van der Poorten D, Xu A, Bugianesi E, Kench JG, Lam KS, Chisholm DJ, George J.

Hepatology. 2009 Jun;49(6):1926-34. doi: 10.1002/hep.22896.

PMID:
19475694
3.

Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.

Suh JB, Kim SM, Cho GJ, Choi KM.

Scand J Gastroenterol. 2014 Aug;49(8):979-85. doi: 10.3109/00365521.2013.836754. Epub 2014 Jun 24.

PMID:
24957697
4.

Irisin in patients with nonalcoholic fatty liver disease.

Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS.

Metabolism. 2014 Feb;63(2):207-17. doi: 10.1016/j.metabol.2013.09.013. Epub 2013 Oct 18.

PMID:
24140091
5.

Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis.

Pohl R, Haberl EM, Rein-Fischboeck L, Zimny S, Neumann M, Aslanidis C, Schacherer D, Krautbauer S, Eisinger K, Weiss TS, Buechler C.

Eur J Clin Invest. 2017 Jan;47(1):7-18. doi: 10.1111/eci.12695. Epub 2016 Nov 21.

PMID:
27797398
6.

Serum chemerin and vaspin in non-alcoholic fatty liver disease.

Kukla M, Zwirska-Korczala K, Hartleb M, Waluga M, Chwist A, Kajor M, Ciupinska-Kajor M, Berdowska A, Wozniak-Grygiel E, Buldak R.

Scand J Gastroenterol. 2010;45(2):235-42. doi: 10.3109/00365520903443852.

PMID:
20095887
7.

Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease.

Yilmaz Y, Yonal O, Kurt R, Alahdab YO, Eren F, Ozdogan O, Celikel CA, Imeryuz N, Kalayci C, Avsar E.

Scand J Gastroenterol. 2011 Jan;46(1):91-7. doi: 10.3109/00365521.2010.516452. Epub 2010 Sep 1.

PMID:
20809771
8.

Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD).

Hatziagelaki E, Herder C, Tsiavou A, Teichert T, Chounta A, Nowotny P, Pacini G, Dimitriadis G, Roden M.

PLoS One. 2015 May 1;10(5):e0124935. doi: 10.1371/journal.pone.0124935. eCollection 2015.

9.

Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes.

Kim SH, Lee SH, Ahn KY, Lee DH, Suh YJ, Cho SG, Choi YJ, Lee DH, Lee SY, Hong SB, Kim YS, Jeon JY, Nam M.

Clin Endocrinol (Oxf). 2014 Jun;80(6):825-33. doi: 10.1111/cen.12249. Epub 2013 Jun 20.

PMID:
23682797
10.

Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease.

Döcke S, Lock JF, Birkenfeld AL, Hoppe S, Lieske S, Rieger A, Raschzok N, Sauer IM, Florian S, Osterhoff MA, Heller R, Herrmann K, Lindenmüller S, Horn P, Bauer M, Weickert MO, Neuhaus P, Stockmann M, Möhlig M, Pfeiffer AF, von Loeffelholz C.

Eur J Endocrinol. 2013 Oct 1;169(5):547-57. doi: 10.1530/EJE-13-0112. Print 2013 Nov.

11.

Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.

Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, Bedossa P, Tordjman J, Eckel J, Clément K.

J Clin Endocrinol Metab. 2010 Jun;95(6):2892-6. doi: 10.1210/jc.2009-2374. Epub 2010 Apr 7.

PMID:
20375212
12.

Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease.

Auguet T, Terra X, Quintero Y, Martínez S, Manresa N, Porras JA, Aguilar C, Orellana-Gavaldà JM, Hernández M, Sabench F, Lucas A, Pellitero S, Del Castillo D, Richart C.

Exp Clin Endocrinol Diabetes. 2013 Feb;121(2):119-24. doi: 10.1055/s-0032-1331696. Epub 2013 Feb 20.

PMID:
23426707
13.

Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people.

Huang Y, Yang Z, Ye Z, Li Q, Wen J, Tao X, Chen L, He M, Wang X, Lu B, Zhang Z, Zhang W, Qu S, Hu R.

Cardiovasc Diabetol. 2012 Jan 31;11:11. doi: 10.1186/1475-2840-11-11.

14.

Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.

Farhangi MA, Alipour B, Jafarvand E, Khoshbaten M.

Arch Med Res. 2014 Oct;45(7):589-95. doi: 10.1016/j.arcmed.2014.11.001. Epub 2014 Nov 11.

PMID:
25450583
15.

Lipocalin-2, A-FABP and inflammatory markers in relation to flow-mediated vasodilatation in patients with essential hypertension.

Park CG, Choi KM.

Clin Exp Hypertens. 2014;36(7):478-83. doi: 10.3109/10641963.2013.863320. Epub 2014 Feb 3.

PMID:
24491219
16.
17.

Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity.

Bekaert M, Ouwens DM, Hörbelt T, Van de Velde F, Fahlbusch P, Herzfeld de Wiza D, Van Nieuwenhove Y, Calders P, Praet M, Hoorens A, Geerts A, Verhelst X, Kaufman JM, Lapauw B.

Obesity (Silver Spring). 2016 Dec;24(12):2544-2552. doi: 10.1002/oby.21674. Epub 2016 Oct 21.

PMID:
27768254
18.

Serum Chemerin in Obese Children and Adolescents Before and After L-Carnitine Therapy: Relation to Nonalcoholic Fatty Liver Disease and Other Features of Metabolic Syndrome.

Hamza RT, Elkabbany ZA, Shedid AM, Hamed AI, Ebrahim AO.

Arch Med Res. 2016 Oct;47(7):541-549. doi: 10.1016/j.arcmed.2016.11.010.

PMID:
28262196
19.

Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease.

Choi KM, Lee JS, Kim EJ, Baik SH, Seo HS, Choi DS, Oh DJ, Park CG.

Eur J Endocrinol. 2008 Feb;158(2):203-7. doi: 10.1530/EJE-07-0633.

20.

Retinol-binding protein 4 and lipocalin-2 in childhood and adolescent obesity: when children are not just "small adults".

Kanaka-Gantenbein C, Margeli A, Pervanidou P, Sakka S, Mastorakos G, Chrousos GP, Papassotiriou I.

Clin Chem. 2008 Jul;54(7):1176-82. doi: 10.1373/clinchem.2007.099002. Epub 2008 May 16.

Supplemental Content

Support Center